(Q46894994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Combination therapy for choroidal neovascularisation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Prof. Dr. Albert J. Augustin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Indre Offermann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

979-990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

26 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200724120-00002

Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study

21 January 2018

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.

1 reference

12 December 2020

Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration

1 reference

12 December 2020

Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone

1 reference

12 December 2020

Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes

1 reference

12 December 2020

Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism

1 reference

12 December 2020

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

1 reference

12 December 2020

14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study

1 reference

12 December 2020

Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect.

1 reference

12 December 2020

Status of TTT in the therapy for CNV

1 reference

12 December 2020

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration

1 reference

12 December 2020

Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia

1 reference

12 December 2020

Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis

1 reference

12 December 2020

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

1 reference

12 December 2020

Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration

1 reference

12 December 2020

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

12 December 2020

Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration

1 reference

12 December 2020

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration

1 reference

12 December 2020

Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration

1 reference

12 December 2020

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial

1 reference

12 December 2020

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

12 December 2020

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

1 reference

12 December 2020

The role of vascular endothelial growth factor in ocular health and disease

1 reference

12 December 2020

Complement factor H polymorphism in age-related macular degeneration.

1 reference

12 December 2020

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

1 reference

12 December 2020

1 reference

12 December 2020

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

1 reference

12 December 2020

Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study

1 reference

12 December 2020

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

12 December 2020

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.

1 reference

12 December 2020

Prevalence of age-related macular degeneration in the United States

1 reference

12 December 2020

Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization

1 reference

12 December 2020

Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

1 reference

12 December 2020

Vision loss in younger patients: a review of choroidal neovascularization

1 reference

12 December 2020

Emerging drugs for age-related macular degeneration

1 reference

12 December 2020

Doctor, what vitamins should I take for my eyes?

1 reference

12 December 2020

The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study

1 reference

12 December 2020

The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study.

1 reference

12 December 2020

Pegaptanib for neovascular age-related macular degeneration

1 reference

12 December 2020

Evolving European guidance on the medical management of neovascular age related macular degeneration

1 reference

12 December 2020

1 reference

12 December 2020

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

1 reference

12 December 2020

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

1 reference

12 December 2020

Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.

1 reference

12 December 2020

Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.

1 reference

12 December 2020

[The place of surgery in subfoveal neovascular treatment in age-related macular degeneration]

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration

1 reference

12 December 2020

Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration.

1 reference

12 December 2020

Nutrition and age-related macular degeneration

1 reference

12 December 2020

Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration.

1 reference

12 December 2020

Five-year incidence of age-related maculopathy: the Visual Impairment Project

1 reference

12 December 2020

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration

1 reference

12 December 2020

Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER.

1 reference

12 December 2020

Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study

1 reference

12 December 2020

Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration

1 reference

12 December 2020

Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin

1 reference

12 December 2020

Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor

1 reference

12 December 2020

Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone.

1 reference

12 December 2020

Rationale for combination therapies for choroidal neovascularization

1 reference

12 December 2020

Intravitreal triamcinolone acetonide in exudative age-related macular degeneration

1 reference

12 December 2020

Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study

1 reference

12 December 2020

Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS)

1 reference

12 December 2020

Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome

1 reference

12 December 2020

Ranibizumab: Phase III clinical trial results

1 reference

12 December 2020

Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study

1 reference

12 December 2020

Assessment of the contribution of the LOC387715 gene polymorphism in a family with exudative age-related macular degeneration and heterozygous CFH variant (Y402H).

1 reference

12 December 2020

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

12 December 2020

Role of genetic factors and inflammation in age-related macular degeneration

1 reference

12 December 2020

Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT)

1 reference

12 December 2020

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study

1 reference

12 December 2020

10.2165/00002512-200724120-00002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020531%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 December 2019

1049575165

0 references

1 reference